Skip to main content

CORRECTION article

Front. Immunol., 03 May 2023
Sec. Immunological Tolerance and Regulation
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1210147
This article is part of the Research Topic Insights in Immunological Tolerance and Regulation: 2022 View all 13 articles

Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines?

This article is a correction to:

  1. Can vitamin D status influence seroconversion to SARS-COV2 vaccines?

    1. Read original article
Endrit Shahini*Endrit Shahini1*Francesco PesceFrancesco Pesce2Antonella ArgentieroAntonella Argentiero3Antonio Giovanni SolimandoAntonio Giovanni Solimando4
  • 1Gastroenterology Unit, National Institute of Gastroenterology S. De Bellis Research Hospital (IRCCS), Castellana Grotte, Italy
  • 2Nephrology, Dialysis and Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J), University of Bari “A. Moro”, Bari, Italy
  • 3Medical Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Bari, Italy
  • 4Guido Baccelli Unit of Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J), University of Bari “A. Moro”, Bari, Italy

A Corrigendum on
Can vitamin D status influence seroconversion to SARS-COV2 vaccines?

by Shahini E, Pesce F, Argentiero A and Solimando AG (2022) Front. Immunol. 13:1038316. doi: 10.3389/fimmu.2022.1038316

In the published article, there was an error in affiliation 1. Instead of “National Institute of Research “Saverio De Bellis”, Castellana Grotte, Italy”, it should be “Gastroenterology Unit, National Institute of Gastroenterology S. De Bellis Research Hospital (IRCCS), Castellana Grotte, Italy”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: COVID-19, coronavirus, vitamin D, antibodies, serology, autoimmune disorders, pneumonia

Citation: Shahini E, Pesce F, Argentiero A and Solimando AG (2023) Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines? Front. Immunol. 14:1210147. doi: 10.3389/fimmu.2023.1210147

Received: 21 April 2023; Accepted: 25 April 2023;
Published: 03 May 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Shahini, Pesce, Argentiero and Solimando. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Endrit Shahini, endrit.shahini@irccsdebellis.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.